Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP).

Full DD Report for SGYP

You must become a subscriber to view this report.


Recent News from (NASDAQ: SGYP)

Synergy Pharmaceuticals: Why Does The Company Keep Pushing Its CRG Loan Borrowing Dates?
Investors in Synergy Pharmaceuticals ( SGYP ) have recently been extremely disappointed by the lack of communication and understanding about what's been happening inside the company. The company has gone in silent mode and that has a lot of investors fretting about what the future might look l...
Source: SeekingAlpha
Date: September, 12 2018 16:53
Market Trends Toward New Normal in Sykes Enterprises, Carnival, Covenant Transportation Group, Synergy Pharmaceuticals, Regeneron Pharmaceuticals, and Minerals Technologies - Emerging Consolidated Expectations, Analyst Ratings
NEW YORK, Aug. 31, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Sykes Enterprises, Incorporated (NASDAQ:SYKE), Carnival Corporation (NYSE...
Source: GlobeNewswire
Date: August, 31 2018 08:00
Synergy Investment Group Has A New Target: The Shorts
The Synergy Investment Group , a group of over 1,030 investors who have claimed to collectively own 37.5 million shares in Synergy Pharmaceuticals ( SGYP ) is losing no time to pick a new target after its victory on defeating shareholder-unfriendly proposals. This time the group is going afte...
Source: SeekingAlpha
Date: August, 29 2018 08:15
Synergy Pharmaceuticals: Troy Hamilton Continues To Deliver
Synergy Pharmaceuticals ( SGYP ) CEO Troy Hamilton is quickly proving to be a very capable CEO and is proving skeptics that he understands what's needed to be done to turn the company around. In order for the share price to recover, three things needed to happen: Insurance wins, cash burn re...
Source: SeekingAlpha
Date: August, 24 2018 11:38

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-141.701.661.741.651,773,192
2018-05-211.641.601.67991.572,600,500
2018-05-181.681.641.721.622,561,432
2018-05-171.771.661.771.632,725,302
2018-05-161.751.751.781.703,365,906

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-146,490,84012,231,77753.0654Short
2018-12-131,337,4544,756,27928.1198Cover
2018-12-127,156,96724,297,66629.4554Cover
2018-12-11734,2571,167,98962.8651Short
2018-12-10546,6921,023,31153.4238Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on SGYP.


About Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP)

Logo for Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP)

Synergy Pharmaceuticals, Inc. SGYP.PK is a public, development stage biopharmaceutical company focused on drugs to treat gastrointestinal GI conditions and diseases

 

 

 

Current Management

  • Gary S. Jacob / President, CEO
  • Gabriele Cerrone / Chairman

Current Share Structure

  • Market Cap: $404,523,002 - 05/18/2018
  • Issue and Outstanding: 246,660,367 - 03/01/2018

 


Recent Filings from (NASDAQ: SGYP)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 31 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 07 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 12 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 06 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: May, 31 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 29 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: May, 15 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018

 

 


Daily Technical Chart for (NASDAQ: SGYP)

Daily Technical Chart for (NASDAQ: SGYP)


Stay tuned for daily updates and more on (NASDAQ: SGYP)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: SGYP)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in SGYP is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of SGYP and does not buy, sell, or trade any shares of SGYP. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/